Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 81
Filter
2.
Cell Death Dis ; 4: e573, 2013 Apr 04.
Article in English | MEDLINE | ID: mdl-23559007

ABSTRACT

Cigarette smoke (CS) is a main risk factor for chronic obstructive pulmonary disease (COPD). Oxidative stress induced by CS causes DNA and lung damage. Oxidant/antioxidant imbalance occurs in the distal air spaces of smokers and in patients with COPD. We studied the effect of oxidative stress generated by CS both in vivo and in vitro on murine primary alveolar type II (ATII) cells isolated from nuclear erythroid 2-related factor-2 (Nrf2)(-/-) mice. We determined human primary ATII cell injury by CS in vitro and analyzed ATII cells isolated from smoker and non-smoker lung donors ex vivo. We also studied whether trolox (water-soluble derivative of vitamin E) could protect murine and human ATII cells against CS-induced DNA damage and/or decrease injury. We analyzed oxidative stress by 4-hydroxynonenal expression, reactive oxygen species (ROS) generation by Amplex Red Hydrogen Peroxide Assay, Nrf2, heme oxygenase 1, p53 and P53-binding protein 1 (53BP1) expression by immonoblotting, Nrf2 nuclear translocation, Nrf2 and p53 DNA-binding activities, apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay and cytokine production by ELISA. We found that ATII cells isolated from Nrf2(-/-) mice are more susceptible to CS-induced oxidative DNA damage mediated by p53/53BP1 both in vivo and in vitro compared with wild-type mice. Therefore, Nrf2 activation is a key factor to protect ATII cells against injury by CS. Moreover, trolox abolished human ATII cell injury and decreased DNA damage induced by CS in vitro. Furthermore, we found higher inflammation and p53 mRNA expression by RT-PCR in ATII cells isolated from smoker lung donors in comparison with non-smokers ex vivo. Our results indicate that the Nrf2 and p53 cross talk in ATII cells affect the susceptibility of these cells to injury by CS. Trolox can protect against oxidative stress, genotoxicity and inflammation induced by CS through ROS scavenging mechanism, and serve as a potential antioxidant prevention strategy against oxidative injury of ATII cells in CS-related lung diseases.


Subject(s)
Alveolar Epithelial Cells/drug effects , Antioxidants/pharmacology , Chromans/pharmacology , NF-E2-Related Factor 2/agonists , Nicotiana/toxicity , Pulmonary Alveoli/drug effects , Tumor Suppressor Protein p53/agonists , Aldehydes/metabolism , Alveolar Epithelial Cells/cytology , Alveolar Epithelial Cells/metabolism , Animals , Gene Expression Regulation/drug effects , Heme Oxygenase-1/genetics , Heme Oxygenase-1/metabolism , Humans , Intracellular Signaling Peptides and Proteins/genetics , Intracellular Signaling Peptides and Proteins/metabolism , Mice , Mice, Knockout , NF-E2-Related Factor 2/genetics , NF-E2-Related Factor 2/metabolism , Oxidative Stress , Pulmonary Alveoli/cytology , Pulmonary Alveoli/metabolism , Reactive Oxygen Species/antagonists & inhibitors , Reactive Oxygen Species/metabolism , Signal Transduction/drug effects , Smoke/adverse effects , Smoking/adverse effects , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism , Tumor Suppressor p53-Binding Protein 1
3.
Clin Microbiol Infect ; 17(1): 15-24, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20636425

ABSTRACT

Parasitic diseases have been known to cause pulmonary vascular lesions. Schistosomiasis is the most common parasitic disease associated with pulmonary arterial hypertension, although other trematodes have been implicated. Systematic evaluation of and interest in this problem have been rekindled because of the current availability of pulmonary arterial hypertension treatment.


Subject(s)
Lung Diseases, Parasitic/complications , Lung Diseases, Parasitic/immunology , Schistosomiasis/complications , Schistosomiasis/immunology , Vascular Diseases/immunology , Animals , Familial Primary Pulmonary Hypertension , Humans , Hypertension, Pulmonary/complications , Hypertension, Pulmonary/immunology , Hypertension, Pulmonary/pathology , Schistosoma/physiology , Schistosomiasis/pathology , Vascular Diseases/parasitology
4.
J Cell Death ; 2010(3): 41-53, 2010 Jul 20.
Article in English | MEDLINE | ID: mdl-22081757

ABSTRACT

Apoptosis is an important contributor to the pathophysiology of lung diseases such as acute lung injury (ALI) and chronic obstructive pulmonary disease (COPD). Furthermore, the cellular environment of these acute and chronic lung diseases favors the delayed clearance of apoptotic cells. This dysfunctional efferocytosis predisposes to the release of endogenous ligands from dying cells. These so-called damage-associated molecular patterns (DAMPs) play an important role in the stimulation of innate immunity as well as in the induction of adaptive immunity, potentially against autoantigens. In this review, we explore the role of apoptosis in ALI and COPD, with particular attention to the contribution of DAMP release in augmenting the inflammatory response in these disease states.

5.
J Cell Death ; 3: 41-53, 2010.
Article in English | MEDLINE | ID: mdl-28469476

ABSTRACT

Apoptosis is an important contributor to the pathophysiology of lung diseases such as acute lung injury (ALI) and chronic obstructive pulmonary disease (COPD). Furthermore, the cellular environment of these acute and chronic lung diseases favors the delayed clearance of apoptotic cells. This dysfunctional efferocytosis predisposes to the release of endogenous ligands from dying cells. These so-called damage-associated molecular patterns (DAMPs) play an important role in the stimulation of innate immunity as well as in the induction of adaptive immunity, potentially against autoantigens. In this review, we explore the role of apoptosis in ALI and COPD, with particular attention to the contribution of DAMP release in augmenting the inflammatory response in these disease states.

6.
Thorax ; 63(5): 463-9, 2008 May.
Article in English | MEDLINE | ID: mdl-18443163

ABSTRACT

Chronic lung diseases are increasingly recognised complications of the human immunodeficiency virus (HIV) infection and acquired immune deficiency syndrome (AIDS). Of these, pulmonary emphysema, characterised by permanent destruction of the lung parenchyma distal to the terminal bronchioles accompanied by various degrees of inflammation, is emerging as a distinct source of morbidity for patients infected with HIV. Similarly, HIV is now frequently cited as a susceptibility factor for the development of emphysema, independent of cigarette smoking status. The presence of common coexistent confounding factors that may predispose patients to chronic lung injury such as drugs, opportunistic infections and malnutrition, limits the scope of studies of direct mechanisms involved in HIV associated emphysematous lung disease. We review the clinical studies supporting a direct association between HIV infection and emphysema. Recent developments in the basic understanding of HIV infection and emphysema are also reviewed, since they may aid in understanding the pathobiology of HIV associated emphysema. The authors emphasise how HIV infection may affect cytotoxic lymphocyte activation, lung capillary endothelial cell injury and apoptosis, sphingolipid imbalance and oxidative stress in the lung. A better understanding of the pathogenesis of HIV associated pulmonary emphysema may provide clues and therapeutic targets that have broader application in this disease, including cigarette smoke induced emphysema.


Subject(s)
HIV Infections/complications , Pulmonary Emphysema/virology , Apoptosis/physiology , Endothelial Cells , HIV Infections/diagnostic imaging , HIV Infections/pathology , Humans , Models, Biological , Oxidative Stress/physiology , Pneumonia, Viral/etiology , Pulmonary Emphysema/diagnostic imaging , Pulmonary Emphysema/pathology , Smoking/adverse effects , Tomography, X-Ray Computed
7.
Am J Physiol Lung Cell Mol Physiol ; 294(4): L601-11, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18178675

ABSTRACT

Apoptosis and other forms of programmed cell death are important contributors to lung pathophysiology. In this brief review, we discuss some of the implications of finding apoptotic cells in the lung and methods for their detection. The balance between induction of apoptosis and the normally highly efficient clearance of such cells shows that these are highly dynamic processes and suggests that abnormalities of apoptotic cell clearance may be an alternative explanation for their detection. Because recognition of apoptotic cells by other lung cells has additional effects on inflammation, immunity, and tissue repair, local responses to the dying cells may also have important consequences in addition to the cell death itself.


Subject(s)
Apoptosis/physiology , Lung/cytology , Lung/physiology , Animals , DNA Fragmentation , Humans , Kinetics , Lung/pathology , Necrosis
8.
J Am Coll Cardiol ; 43(12 Suppl S): 25S-32S, 2004 Jun 16.
Article in English | MEDLINE | ID: mdl-15194175

ABSTRACT

Pulmonary arterial hypertension (PAH) includes various forms of pulmonary hypertension of different etiology but similar clinical presentation and functional derangement. Histopathological vascular changes in all forms of PAH are qualitatively similar but with quantitative differences in the distribution and prevalence of pathological changes in various portions of the pulmonary vascular bed. The documentation of these topographic variations in the response of the pulmonary vasculature to injury may be important to understand the pathogenesis of the various subsets of PAH. To standardize the precise histopathological documentation of the pulmonary vasculopathy in PAH we propose a histopathological classification that includes both the predominant segment of the pulmonary vasculature affected and the possible coexistence of pathological changes in other vascular segments.


Subject(s)
Hypertension, Pulmonary/pathology , Lung/blood supply , Vascular Diseases/pathology , Humans , Hypertension, Pulmonary/physiopathology , Muscle, Smooth, Vascular/pathology , Muscle, Smooth, Vascular/physiopathology , Pulmonary Artery/pathology , Pulmonary Artery/physiopathology , Pulmonary Circulation/physiology , Tunica Intima/pathology , Tunica Intima/physiopathology , Vascular Resistance/physiology , Vasoconstriction/physiology
9.
Crit Rev Comput Tomogr ; 45(5-6): 335-41, 2004.
Article in English | MEDLINE | ID: mdl-15747574

ABSTRACT

Primary pulmonary arterial hypertension is a rare lethal disease that typically presents radiographically with enlarged central pulmonary arteries, pruning of the peripheral vasculature, and cardiomegaly but clear lung fields. Although it is a disease of unknown etiology, primary PAH has been associated with anorexigen use. We present a case of pulmonary arterial hypertension in a woman with a history of fenfluramine and phentermine use who presented with diffuse micronodules on computed tomography scan. Lung biopsy confirmed the micronodules were radiographic manifestations of extensive diffuse plexogenic arterial lesions. This report represents an unusual radiographic presentation of anorexigen related pulmonary arterial hypertension, and to our knowledge, the first case reported as presenting with diffuse micronodules on high resolution computed tomography scan.


Subject(s)
Hypertension, Pulmonary/diagnostic imaging , Tomography, X-Ray Computed , Adult , Appetite Depressants/adverse effects , Asthma/complications , Drug Combinations , Female , Fenfluramine/adverse effects , Humans , Hypertension, Pulmonary/chemically induced , Hypertension, Pulmonary/complications , Hypertrophy , Lung/blood supply , Obesity , Phentermine/adverse effects , Pulmonary Artery/diagnostic imaging , Pulmonary Artery/pathology , Radiographic Image Enhancement
10.
Eur Respir J ; 19(1): 20-30, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11843321

ABSTRACT

In obliterative bronchiolitis, inflammation and fibrosis lead to narrowing or occlusion of bronchiolar lumina. To determine how bronchiolar structural alterations relate to lung physiology, 19 patients with a pathological diagnosis of obliterative bronchiolitis were studied. The bronchiolar inflammatory and fibrotic features were correlated to the clinical presentation, and lung function tests. Eleven patients demonstrated airflow limitation, one had a restrictive pattern and one had a mixed pattern, two had isolated gas trapping, but four had normal spirometry. Mild-to-moderate bronchiolar inflammation was invariably present. It involved 60% of bronchioles subepithelially and 54% in the adventitia. Subepithelial fibrosis was observed in 15 patients and adventitial in 12. Adventitial bronchiolar inflammation correlated with forced expiratory volume in one second and forced vital capacity and inversely correlated with residual volume. Subepithelial fibrosis inversely correlated with subepithelial and adventitial inflammation. High-resolution computed tomography in 10 patients revealed inspiratory (five out of 10) and expiratory air trapping (five out of five), ground glass opacities (seven out of 10), bronchial wall thickening (five out of 10), bronchiectasis (two out of 10) and centrilobular nodules (two out of 10). The present study suggests that inflammation and fibrosis occurs in bronchioles at different time points in the disease process, or that there is no transition between these types of pathology in the same patient. No correlation was observed between the degree of bronchiolar fibrosis and the degree of airflow limitation.


Subject(s)
Bronchiolitis Obliterans/pathology , Bronchiolitis Obliterans/physiopathology , Adult , Bronchiolitis Obliterans/diagnostic imaging , Female , Humans , Inflammation/pathology , Lung/pathology , Male , Middle Aged , Pulmonary Fibrosis/pathology , Spirometry , Tomography, X-Ray Computed
11.
Respir Res ; 2(4): 210-5, 2001.
Article in English | MEDLINE | ID: mdl-11686886

ABSTRACT

Genomics, or the study of genes and their function, is a burgeoning field with many new technologies. In the present review, we explore the application of genomic approaches to the study of pulmonary hypertension (PH). Candidate genes, important to the pathobiology of the disease, have been investigated. Rodent models enable the manipulation of selected genes, either by transgenesis or targeted disruption. Mutational analysis of genes in the transforming growth factor-beta family have proven pivotal in both familial and sporadic forms of primary PH. Finally, microarray gene expression analysis is a robust molecular tool to aid in delineating the pathobiology of this disease.


Subject(s)
Hypertension, Pulmonary/genetics , Animals , Disease Models, Animal , Humans , Mice , Mice, Transgenic , Mutation , Oligonucleotide Array Sequence Analysis
12.
Am J Physiol Cell Physiol ; 281(5): C1422-33, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11600404

ABSTRACT

Endothelium critically regulates systemic and pulmonary vascular function, playing a central role in hemostasis, inflammation, vasoregulation, angiogenesis, and vascular growth. Indeed, the endothelium integrates signals originating in the circulation with those in the vessel wall to coordinate vascular function. This highly metabolic role differs significantly from the historic view of endothelium, in which it was considered to be merely an inert barrier. New lines of evidence may further change our understanding of endothelium, in regard to both its origin and function. Embryological studies suggest that the endothelium arises from different sites, including angiogenesis of endothelium from macrovascular segments and vasculogenesis of endothelium from microcirculatory segments. These findings suggest an inherent phenotypic distinction between endothelial populations based on their developmental origin. Similarly, diverse environmental cues influence endothelial cell phenotype, critical to not only normal function but also the function of a diseased vessel. Consequently, an improved understanding of site-specific endothelial cell function is essential, particularly with consideration to environmental stimuli present both in the healthy vessel and in development of vasculopathic disease states. The need to examine endothelial cell phenotypes in the context of vascular function served as the basis for a recent workshop sponsored by the National Heart, Lung, and Blood Institute (NHLBI). This report is a synopsis of pertinent topics that were discussed, and future goals and research opportunities identified by the participants of the workshop are presented.


Subject(s)
Endothelium, Vascular/pathology , Heart Diseases/pathology , Hematologic Diseases/pathology , Lung Diseases/pathology , Animals , Cell Communication/physiology , Endothelium, Vascular/cytology , Heart Diseases/blood , Hematologic Diseases/blood , Humans , Lung Diseases/blood , Phenotype
13.
J Pathol ; 195(3): 367-74, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11673836

ABSTRACT

Pulmonary arteries of patients with severe pulmonary hypertension (SPH) presenting in an idiopathic form (primary PH-PPH) or associated with congenital heart malformations or collagen vascular diseases show plexiform lesions. It is postulated that in lungs with SPH, endothelial cells in plexiform lesions express genes encoding for proteins involved in angiogenesis, in particular, vascular endothelial growth factor (VEGF) and those involved in VEGF receptor-2 (VEGFR-2) signalling. On immunohistochemistry and in situ hybridization, endothelial cells in the plexiform lesions expressed VEGF mRNA and protein and overexpressed the mRNA and protein of VEGFR-2, and the transcription factor subunits HIF-1alpha and HIF-1beta of hypoxia inducible factor, which are responsible for the hypoxia-dependent induction of VEGF. When compared with normal lungs, SPH lungs showed decreased expression of the kinases PI3 kinase and src, which, together with Akt, relay the signal transduction downstream of VEGFR-2. Because markers of angiogenesis are expressed in plexiform lesions in SPH, it is proposed that these lesions may form by a process of disordered angiogenesis.


Subject(s)
DNA-Binding Proteins , Endothelial Growth Factors/analysis , Hypertension, Pulmonary/metabolism , Lymphokines/analysis , Pulmonary Artery/metabolism , Receptor Protein-Tyrosine Kinases/analysis , Receptors, Aryl Hydrocarbon , Receptors, Growth Factor/analysis , Aryl Hydrocarbon Receptor Nuclear Translocator , Biomarkers/analysis , Case-Control Studies , Endothelial Growth Factors/genetics , Humans , Hypertension, Pulmonary/pathology , Hypoxia-Inducible Factor 1, alpha Subunit , In Situ Hybridization/methods , Lymphokines/genetics , Neovascularization, Pathologic , Oligopeptides/analysis , Phosphatidylinositol 3-Kinases/analysis , Pulmonary Artery/pathology , RNA, Messenger/analysis , Receptor Protein-Tyrosine Kinases/genetics , Receptors, Growth Factor/genetics , Receptors, Vascular Endothelial Growth Factor , Transcription Factors/analysis , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
14.
Clin Chest Med ; 22(3): 405-18, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11590837

ABSTRACT

Dysfunctional endothelial cells have a central and critical role in the initiation and progression of severe pulmonary hypertension. The elucidation of the mechanisms involved in the control of endothelial cell proliferation and cell death in the pulmonary vasculature, therefore, is fundamentally important in the pathogenesis of severe pulmonary hypertension and of great interest for a better understanding of endothelial cell biology. Because the intravascular growth of endothelial cells resulting in tumorlets is unique to severe pulmonary hypertension, this phenomenon can teach researchers about the factors involved in the formation and maintenance of the normal endothelial cell monolayer. Clearly, in severe pulmonary hypertension, the "law of the endothelial cell monolayer" has been broken. The ultimate level of such a control is at the altered gene expression pattern that is conducive to endothelial cell growth and disruption of pulmonary blood flow. Secondary pulmonary hypertension certainly also is associated with proliferated pulmonary endothelial cells and plexiform lesions that are histologically indistinguishable from those in PPH. What is then the difference in the mechanisms of endothelial cell proliferation between primary and secondary pulmonary hypertension? The authors believe that PPH is a disease caused by somatic mutations in key angiogenesis- or apoptosis-related genes such as the TGF-beta receptor-2 and Bax. The loss of these important cell growth control mechanisms allows for the clonal expansion of endothelial cells from a single cell that has acquired a selective growth advantage. On the other hand, the proliferated endothelial cells in secondary pulmonary hypertension are polyclonal. It follows from this finding that local (vascular) factor(s) (such as increased shear stress), rather than mutations, play a major role in triggering endothelial cell proliferation. In PPH and secondary pulmonary hypertension, the researcher can postulate that the pulmonary vascular bed contains progenitor-like cells with the capacity of dysregulated growth. The main difference in the pathogenesis of primary and secondary pulmonary endothelial cell proliferation therefore may be the initial mechanism involved in the recruitment of an endothelial progenitor-like cell. In PPH, anorexigen-associated, and familial PPH, the proliferation of endothelial cells occurs from a mutated single cell, whereas in secondary pulmonary hypertension, several progenitor-like cells would be activated to grow. The abnormal endothelial cells in both forms of severe pulmonary hypertension expand because of the expression of angiogenesis-related molecules such as VEGF, VEGFR-2, HIF-1 alpha, and HIF-beta. Also important for the expansion of these cells is the down-regulation of expression of apoptosis-related mediators such as TGF-beta receptor-2 or Bax. The success of any therapy for severe pulmonary hypertension requires that the underlying process of endothelial cell proliferation could be controlled or reversed.


Subject(s)
Endothelium, Vascular/physiopathology , Hypertension, Pulmonary/physiopathology , Animals , Blood Coagulation/physiology , Cytochrome P-450 Enzyme System/metabolism , Endothelial Growth Factors/metabolism , Endothelium, Vascular/pathology , Humans , Hypertension, Pulmonary/genetics , Hypertension, Pulmonary/pathology , Intramolecular Oxidoreductases/metabolism , Lymphokines/metabolism , Microsatellite Repeats , Muscle, Smooth, Vascular/pathology , Muscle, Smooth, Vascular/physiopathology , Mutation , Nitric Oxide/metabolism , Protein Isoforms/metabolism , Pulmonary Artery/pathology , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors , Vasoconstriction
15.
Am J Respir Crit Care Med ; 164(7): 1282-7, 2001 Oct 01.
Article in English | MEDLINE | ID: mdl-11673223

ABSTRACT

The plasma endothelin-1 (ET-1) level is elevated in patients with acute pulmonary thromboembolism (APE). Whether ET-1 is a pathogenic mediator or a simple marker of APE is not known. We investigated the role of ET-1 in hemodynamic dysfunction in APE through evaluating the effects of ET(A) receptor antagonist in an experimental APE model. We also examined ET-1 expression in embolized lungs. In a canine autologous blood clot pulmonary embolism model, ET(A) receptor antagonist ZD2574 (10 mg/kg, intravenous; ZD2574 group; n = 6) or vehicle (control group; n = 5) was administered. Hemodynamic and gas exchange parameters and plasma levels of ET-1 were serially measured. Prepro-ET-1 mRNA expression and the distribution of ET-1 peptide in lung tissues were also examined. With ZD2574 pulmonary arterial pressure and pulmonary vascular resistance significantly decreased, and were lower compared with the control group. The decrease in cardiac output was also less in the ZD2574 group. Plasma ET-1 levels increased after embolization. Prepro-ET-1 mRNA expression increased in embolized lungs and ET-1 peptide expression also increased in embolized lungs, particularly in the muscular pulmonary arteries, compared with normal lungs. These findings suggest that ET-1 partially contributes to hemodynamic derangements of APE, and that ET(A) receptor antagonists might constitute a useful therapeutic tool for APE.


Subject(s)
Endothelin-1/physiology , Hemodynamics , Pulmonary Embolism/physiopathology , Acute Disease , Animals , Dogs , Pulmonary Embolism/pathology
16.
Eur Respir J ; 17(6): 1065-9, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11491145

ABSTRACT

The recent discoveries of the familial primary pulmonary hypertension gene and somatic mutations in key cell growth and cell death regulatory genes in primary pulmonary hypertension have added a new dimension to severe pulmonary hypertension research. These findings have already impacted on how the disease is viewed, and ultimately, how severe pulmonary hypertension is diagnosed and treated. However, this new information raises several fundamental questions related to the role of bone morphogenetic protein receptor signalling in the control of lung vascular cell function. Furthermore, additional genes and gene products may also be involved in the pathogenesis of the disease. The way severe pulmonary hypertension is viewed and studied is on the verge of shifting from a vasoconstrictive to a cell growth paradigm.


Subject(s)
Hypertension, Pulmonary/genetics , Bone Morphogenetic Protein Receptors, Type II , DNA Mutational Analysis , Endothelium, Vascular/physiopathology , Humans , Hypertension, Pulmonary/diagnosis , Hypertension, Pulmonary/physiopathology , Protein Serine-Threonine Kinases/genetics , Receptor, Transforming Growth Factor-beta Type II , Receptors, Transforming Growth Factor beta/genetics , Signal Transduction/physiology
18.
Circ Res ; 88(6): 555-62, 2001 Mar 30.
Article in English | MEDLINE | ID: mdl-11282888

ABSTRACT

Primary pulmonary hypertension (PPH) is a disease of unknown etiology characterized by lumen-obliterating endothelial cell proliferation and vascular smooth muscle hypertrophy of the small precapillary pulmonary arteries. Because the vascular lesions are homogeneously distributed throughout the entire lung, we propose that a tissue fragment of the lung is representative of the whole lung. RNA extracted from the fragments is likely to provide meaningful information regarding the changes in gene expression pattern in PPH when compared with structurally normal lung tissue. We hypothesize that the lung tissue gene expression pattern of patients with PPH has a characteristic profile when compared with the gene expression pattern of structurally normal lungs and that this characteristic gene expression profile provides new insights into the pathobiology of PPH. Using oligonucleotide microarray technology, we characterized the expression pattern in the lung tissue obtained from 6 patients with primary pulmonary hypertension (PPH)-including 2 patients with the familial form of PPH (FPPH)-and from 6 patients with histologically normal lungs. For the data analysis, gene clusters were generated and the gene expression pattern differences between PPH and normal lung tissue and between PPH and FPPH lung tissue were compared. All PPH lung tissue samples showed a decreased expression of genes encoding several kinases and phosphatases, whereas several oncogenes and genes coding for ion channel proteins were upregulated in their expression. Importantly, we could distinguish by pattern comparison between sporadic PPH and FPPH, because alterations in the expression of transforming growth factor-beta receptor III, bone morphogenic protein 2, mitogen-activated protein kinase kinase 5, RACK 1, apolipoprotein C-III, and the gene encoding the laminin receptor 1 were only found in the samples from patients with sporadic PPH, but not in FPPH samples. We conclude that the microarray gene expression technique is a new and useful molecular tool that provides novel information pertinent to a better characterization and understanding of the pathobiology of the distinct clinical phenotypes of pulmonary hypertension.


Subject(s)
Gene Expression Profiling , Hypertension, Pulmonary/genetics , Lung/metabolism , Adult , Female , Humans , Lung/pathology , Male , Middle Aged , Oligonucleotide Array Sequence Analysis , RNA/genetics , RNA/metabolism
19.
Am J Respir Crit Care Med ; 163(3 Pt 1): 737-44, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11254533

ABSTRACT

Emphysema due to cigarette smoking is characterized by a loss of alveolar structures. We hypothesize that the disappearance of alveoli involves apoptosis of septal endothelial cells and a decreased expression of lung vascular endothelial growth factor (VEGF) and its receptor 2 (VEGF R2). By terminal transferase dUTP nick end labeling (TUNEL) in combination with immunohistochemistry, we found that the number of TUNEL+ septal epithelial and endothelial cells/lung tissue nucleic acid (microg) was increased in the alveolar septa of emphysema lungs (14.2 +/- 2.0/microg, n = 6) when compared with normal lungs (6.8 +/- 1.3/microg, n = 7) (p < 0.01) and with primary pulmonary hypertensive lungs (2.3 +/- 0.8/microg, n = 5) (p < 0.001). The cell death events were not significantly different between healthy nonsmoker (7.4 +/- 1.9/microg) and smoker (5.7 +/- 0.7/microg) control subjects. The TUNEL results were confirmed by single-stranded DNA and active caspase-3 immunohistochemistry, and by DNA ligation assay. Emphysema lungs (n = 12) had increased levels of oligonucleosomal-length DNA fragmentation when compared with normal lungs (n = 11). VEGF, VEGF R2 protein, and mRNA expression were significantly reduced in emphysema. We propose that epithelial and endothelial alveolar septal death due to a decrease of endothelial cell maintenance factors may be part of the pathogenesis of emphysema.


Subject(s)
Apoptosis , Emphysema/metabolism , Emphysema/pathology , Endothelial Growth Factors/biosynthesis , ErbB Receptors/biosynthesis , Lymphokines/biosynthesis , Adolescent , Adult , Aged , Emphysema/genetics , Endothelial Growth Factors/analysis , ErbB Receptors/analysis , Female , Humans , In Situ Nick-End Labeling , Lymphokines/analysis , Male , Middle Aged , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
20.
Am J Pathol ; 158(3): 955-66, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11238043

ABSTRACT

HOX genes belong to the large family of homeodomain genes that function as transcription factors. Animal studies indicate that they play an essential role in lung development. We investigated the expression pattern of HOX genes in human lung tissue by using microarray and degenerate reverse transcriptase-polymerase chain reaction survey techniques. HOX genes predominantly from the 3' end of clusters A and B were expressed in normal human adult lung and among them HOXA5 was the most abundant, followed by HOXB2 and HOXB6. In fetal (12 weeks old) and diseased lung specimens (emphysema, primary pulmonary hypertension) additional HOX genes from clusters C and D were expressed. Using in situ hybridization, transcripts for HOXA5 were predominantly found in alveolar septal and epithelial cells, both in normal and diseased lungs. A 2.5-fold increase in HOXA5 mRNA expression was demonstrated by quantitative reverse transcriptase-polymerase chain reaction in primary pulmonary hypertension lung specimens when compared to normal lung tissue. In conclusion, we demonstrate that HOX genes are selectively expressed in the human lung. Differences in the pattern of HOX gene expression exist among fetal, adult, and diseased lung specimens. The altered pattern of HOX gene expression may contribute to the development of pulmonary diseases.


Subject(s)
Genes, Homeobox , Hypertension, Pulmonary/genetics , Lung/metabolism , Pulmonary Emphysema/genetics , Adult , Animals , Gene Expression Profiling , Homeodomain Proteins/biosynthesis , Homeodomain Proteins/genetics , Humans , Hypertension, Pulmonary/metabolism , Lung/embryology , Mice , Multigene Family , Oligonucleotide Array Sequence Analysis , Phosphoproteins/biosynthesis , Phosphoproteins/genetics , Protein Isoforms/biosynthesis , Protein Isoforms/genetics , Pulmonary Emphysema/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Transcription Factors/biosynthesis , Transcription Factors/genetics , Transcriptional Activation
SELECTION OF CITATIONS
SEARCH DETAIL
...